These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 374088)

  • 1. Absorption of digoxin in severe right heart failure.
    Ohnhaus EE; Vozeh S; Nuesch E
    Eur J Clin Pharmacol; 1979 Mar; 15(2):115-20. PubMed ID: 374088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proceedings: Studies on the digoxin resorption in patients with decompensated right cardiac insufficiency].
    Ohnhaus EE; Vozeh S; Nüesch E
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1782-3. PubMed ID: 1215978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of digoxin in infants.
    Wettrell G; Andersson KE
    Eur J Clin Pharmacol; 1975 Oct; 9(1):49-55. PubMed ID: 1233252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unchanged absorption of digoxin tablets in patients with cardiac failure.
    Meister W; Benowitz NL; Benet LZ
    Pharmacology; 1984; 28(2):90-4. PubMed ID: 6709691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of digoxin: some pitfalls and problems.
    Keller F; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G; Manninen V; Melin J; Apajalahti A
    Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol.
    Carlton LD; Pollack GM; Brouwer KL
    J Pharm Sci; 1996 May; 85(5):473-7. PubMed ID: 8742937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of digoxin in middle-aged and elderly patients in the subacute period of myocardial infarction].
    Iakovlev SV; Glezer MG; Kholodov LE; Mikhaĭlov AA; Grigor'eva EA
    Kardiologiia; 1986 May; 26(5):33-6. PubMed ID: 3735915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of different lots of digoxin tablets from the same manufacturer.
    Lindenbaum J
    Clin Pharmacol Ther; 1975 Mar; 17(3):296-301. PubMed ID: 1091397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Editorial: Bioavailability of digoxin].
    Alva Correa JJ
    Medicina (B Aires); 1974; 34(6):669-70. PubMed ID: 4459667
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES; Nagaraja NV; Derendorf H
    Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin and congestive heart failure.
    Fantini F; Lucchini CR; Padeletti L; Marsilii A; Dolara P; Mannelli M
    Acta Cardiol; 1977; 32(5):353-62. PubMed ID: 304654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
    Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.